Teva Fights For Biaxin Marketing Rights

Law360, New York (April 19, 2007, 12:00 AM EDT) -- A protracted legal battle between Teva Pharmaceuticals USA and Abbott Laboratories took a new turn on Tuesday, with Teva filing a lawsuit seeking a declaratory judgment that its marketing of a generic version of Abbott’s extended-release antibiotic Biaxin is in line with a settlement the companies reached last August.

Teva said in court documents filed Tuesday in the U.S. District Court for the Southern District of New York that it filed the declaratory judgment action after counsel for Abbott told Teva attorneys that Abbott believes Teva’s...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.